ADSL and bacterial infectious disease: Regarding this, among the limited number of novel agents under investigation, AMPs have shown to be promising to ensure their advancement as active agents toward MDR bacterial infections, as well as potential targets for novel antibiofilm therapeutics (Hale and Hancock, 2007).